Business Description
Elevai Labs Inc
NAICS : 541715
SIC : 2833
ISIN : US28622K1043
Description
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.71 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -3.92 | |||||
Beneish M-Score | 38.36 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.71 | |||||
9-Day RSI | 52.68 | |||||
14-Day RSI | 46.2 | |||||
6-1 Month Momentum % | -47.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.05 | |||||
Quick Ratio | 0.54 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 325.43 | |||||
Days Sales Outstanding | 4.13 | |||||
Days Payable | 310.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -117.61 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.21 | |||||
Operating Margin % | -200.16 | |||||
Net Margin % | -191.92 | |||||
FCF Margin % | -247.6 | |||||
ROE % | -268.18 | |||||
ROA % | -133.25 | |||||
ROIC % | -282.15 | |||||
ROC (Joel Greenblatt) % | -794.44 | |||||
ROCE % | -230.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.9 | |||||
PB Ratio | 1.9 | |||||
EV-to-EBIT | -1.16 | |||||
EV-to-EBITDA | -1.17 | |||||
EV-to-Revenue | 2.19 | |||||
EV-to-FCF | -0.88 | |||||
Earnings Yield (Greenblatt) % | -86.21 | |||||
FCF Yield % | -113.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ELAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elevai Labs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2.475 | ||
EPS (TTM) ($) | -0.273 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 46.2 | ||
14-Day ATR ($) | 0.048612 | ||
20-Day SMA ($) | 0.30251 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.2175 - 4.2442 | ||
Shares Outstanding (Mil) | 20.19 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Elevai Labs Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Elevai Labs Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Elevai Labs Inc Frequently Asked Questions
What is Elevai Labs Inc(ELAB)'s stock price today?
The current price of ELAB is $0.32. The 52 week high of ELAB is $4.24 and 52 week low is $0.22.
When is next earnings date of Elevai Labs Inc(ELAB)?
The next earnings date of Elevai Labs Inc(ELAB) is 2024-12-11 Est..
Does Elevai Labs Inc(ELAB) pay dividends? If so, how much?
Elevai Labs Inc(ELAB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |